Hélène Jary
Galapagos (France)(FR)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Parathyroid Disorders and Treatments, Osteoarthritis Treatment and Mechanisms, Advanced biosensing and bioanalysis techniques, Computational Drug Discovery Methods
Most-Cited Works
- → Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis(2021)54 cited
- → Identification of a 4-(Hydroxymethyl)diarylhydantoin as a Selective Androgen Receptor Modulator(2012)51 cited
- → Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases(2024)21 cited
- → New potent calcimimetics: II. Discovery of benzothiazole trisubstituted ureas(2013)20 cited
- → New potent calcimimetics: I. Discovery of a series of novel trisubstituted ureas(2013)14 cited
- → Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector(2024)8 cited
- → Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseases(2025)
- → Rôle des onychoplasties sur la qualité de vie dans le cas d’onycholyse chez les patients traités par docétaxel(2018)